Advice
Recommended for general use within the NHS in Scotland.
REASONS FOR ADVICE
Recommended for general use within the NHS in Scotland as adjunctive therapy to betablockers or as monotherapy in patients insufficiently responsive to, intolerant of or contraindicated to first-line therapy. It should be used under the direction of an ophthalmologist.
Download detailed advice9KB (PDF)
Medicine details
- Medicine name:
- Bimatoprost (Lumigan®)
- SMC ID:
- 07/02
- Indication:
- Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Eye
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 09 August 2002